HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users.
about
Beyond the Pap Smear: Gender-responsive HIV Care for WomenDual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed PatientsPatient-centered care for people living with multimorbidityHIV and aging: emerging research issuesIdentifying the appropriate comparison group for HIV-infected individualsFactors associated with abnormal spirometry among HIV-infected individualsFrailty, HIV infection, and mortality in an aging cohort of injection drug usersCorrelates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.Women, Aging, and HIV: Clinical Issues and Management Strategies.Is HIV a model of accelerated or accentuated aging?HIV-associated obstructive lung diseases: insights and implications for the clinician.Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario.The relationship of physical performance with HIV disease and mortality.Sexual risk behaviors and HIV risk among Americans aged 50 years or older: a reviewHIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.Geriatric Syndromes in Older HIV-Infected Adults.Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General PopulationUptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health Interventions.Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use.Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering.Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infectionVitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.Primary care of women aging with HIV.The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohortPolypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.Assessment of geriatric syndromes and physical function in people living with HIV.Active injection drug-abuse offsets healthcare engagement in HIV-infected patients.Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014.Lessons learned from the first wave of aging with HIV.Depression Among People Who Inject Drugs and Their Intimate Partners in Kazakhstan.Loneliness in Older Adults Living with HIV.Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
P2860
Q26746179-84498406-57E9-4995-B452-E6F3F6FEFEBDQ26768591-E0AE7FD5-19CF-46D9-B374-FE1880B7A188Q27000743-AE7AC8BE-3B2A-4990-BBC2-F9EB8F386441Q27016011-E6F1958A-46D8-48AF-AAB1-441D3E368350Q27028033-E8BBF631-3A5F-4F62-8F10-96D94F75F93DQ28388780-AAB04A25-E26A-4BA5-BF2B-A77EB5AE914AQ28485898-F38BC601-062B-49B3-87FE-38CEBA640372Q30558355-F2CFB753-CF42-40E6-83B9-70B625FF0AC6Q33730038-DED251DF-93A7-4116-98E4-27A7D0691320Q33792651-E1B08240-C06B-4F0E-B402-4F3CAE7F7EA9Q33950594-6491947F-5C19-4BBC-9519-7032A5F77FC1Q34997577-C27CC0EF-90E0-4269-84B4-FB0EC16D8150Q35093858-5EF07E2B-42EE-4DA5-A9D5-2C41EFEAAFD1Q35234602-91339DC6-D8ED-46F0-B294-FF512B55E132Q35541920-CEA8467E-D5C2-40FA-BAE8-5ED84BD82D44Q35575654-DFFD400F-51C0-4E5C-B2F4-66338CD51C06Q35652825-B7656A12-F0DA-45A4-9C5B-BF0597DF63C6Q35748552-1B40B983-2E53-4EFF-8EA6-B46B34DAE11EQ35922456-A947C493-60BF-49CF-8899-A0D2F3E325CEQ36276469-1E84D98C-C837-40A7-84D2-496F65C295E7Q36311127-2E5D3E8C-F050-48D3-A51E-0483E90CC855Q36429076-73AB113F-A46A-4D3E-90AC-FEC9307F2A17Q36733646-A4E95FA8-CF08-4FD8-8111-777A1554B010Q36748931-55FB5ADB-B3D5-4B2A-A874-16A617ACD5DDQ37155210-FFE668DE-7F80-4BB8-8846-A6AA504E2F0BQ37167877-FA135209-115A-46F6-BEE5-1C0DED571D88Q37272968-9BB4C1C0-8441-469A-B6DC-D336897E6189Q37636248-B2A83B95-5A0D-48CB-BBB3-47357EA6F5AAQ38605387-702FF5B7-4383-4C8D-B8C3-C56D88BE49E8Q38927743-5E08A204-5335-4D48-8675-B29AB76F8AC4Q38974942-189AA578-B17A-4BF0-9D1C-1E742589D675Q40183145-95D84C6D-23AF-4D02-94D4-4A8C11CA721AQ40280432-79509C68-CD5B-4C1F-B9E4-3BA555D3F069Q40750446-EB99B629-3414-457C-A52E-1384ABFFE20BQ41173471-00A70618-BE0B-4FD9-B6CE-EF07E51C952CQ43178168-F1B6814F-5523-48F7-9988-C2E4A4D32794Q45958770-D9D036FB-DEE3-4CDA-B9BE-4C98FFE9159DQ57831581-D1B1FB54-2D4A-470D-895E-677FDAD6BC39
P2860
HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV infection, immune suppress ...... ng aging injection drug users.
@ast
HIV infection, immune suppress ...... ng aging injection drug users.
@en
type
label
HIV infection, immune suppress ...... ng aging injection drug users.
@ast
HIV infection, immune suppress ...... ng aging injection drug users.
@en
prefLabel
HIV infection, immune suppress ...... ng aging injection drug users.
@ast
HIV infection, immune suppress ...... ng aging injection drug users.
@en
P2093
P2860
P356
P1476
HIV infection, immune suppress ...... ng aging injection drug users.
@en
P2093
Gregory D Kirk
Megan L Salter
Shruti H Mehta
Vivian F Go
P2860
P304
P356
10.1093/CID/CIR673
P407
P577
2011-10-05T00:00:00Z